Patients undergoing SCS implants due to intractable pain at Siriraj Hospital spinal cord stimulation effectiveness quality-adjusted life year incremental cost-utility ratios cost-utility analysis willingness to pay Thailand
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: CMM group 1) The patients were more than 7 years old 2) The patients suffered from chronic intractable pain from FBSS, PVD or neuropathic pain 3) The patients reported no satisfactory response to previous treatment defined by a pain score (numeric rating scale or NRS) of at least 5 out of 10 for at least 2 years, despite physical therapy, appropriate regimen of pain medication (gabapentin dose of more than 900 mg/day or pregabalin more than 150 mg/day and two or more other pain medications), other pain interventions or surgery. SCS+CMM group Any patients who underwent a successful SCS trial and subsequent implantation.
Exclusion criteria
Exclusion criteria: 1. Refusal to participate in the study 2. Pain due to cancer 3. Difficulty of communication or poor literacy of Thai language
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cost-utility Post-treatment (3 years time points) incremental cost-utility ratio | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain score Post-treatment (1-6 months time points) Numeric rating pain score range: 0-10,Overall pain-related interference Post-treatment (1-6 months time points) Brief Pain Inventory questionnaire (range: 0-70),Utility Post-treatment (1-6 months time points) EQ-5D-5L health questionnaires21(Thai version) | — |
Countries
Thailand
Contacts
Faculty of Medicine Siriraj Hospital, Mahidol University